Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | ||
| Depreciation Amortization | 845 | 372 |
| Income taxes - deferred | 261 | 62 |
| Other Working Capital | 1,047 | -941 |
| Other Operating Activity | -1,372 | 336 |
| Operating Cash Flow | $781 | $-171 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -545 | -804 |
| Purchase Sale Intangibles | -2,594 | -1,444 |
| Investing Cash Flow | $-3,139 | $-2,248 |
| Cash Flows From Financing Activities | ||
| Debt Issued | 625 | 236 |
| Debt Repayment | -544 | -360 |
| Other Financing Activity | 8,117 | 2,217 |
| Financing Cash Flow | $8,198 | $2,093 |
| Beginning Cash Position | 779 | 1,105 |
| End Cash Position | 6,619 | 779 |
| Net Cash Flow | $5,840 | $-326 |
| Free Cash Flow | ||
| Operating Cash Flow | 781 | -171 |
| Capital Expenditure | -3,139 | -2,248 |
| Free Cash Flow | -2,358 | -2,419 |